Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis
出版年份 2022 全文链接
标题
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-06
DOI
10.1186/s12967-022-03511-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic Targeting of DNA Damage Response in Cancer
- (2022) Wonyoung Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
- (2022) Saiama N. Waqar et al. INVESTIGATIONAL NEW DRUGS
- The role of Exosomal miRNAs in cancer
- (2022) Chuanyun Li et al. Journal of Translational Medicine
- Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients
- (2022) Wei Sun et al. Journal of Translational Medicine
- Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
- (2021) Annamaria Colao et al. Frontiers in Endocrinology
- Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
- (2021) Wei-Yu Chen et al. Communications Biology
- The Role of Serum 5-HIAA as a Predictor of Progression and an Alternative to 24-h Urine 5-HIAA in Well-Differentiated Neuroendocrine Neoplasms
- (2021) Maria Wedin et al. Biology-Basel
- Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
- (2021) Andreea Newtson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
- (2021) Akihiro Ohmoto et al. MODERN PATHOLOGY
- Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma
- (2021) Hoda Saghaeiannejad Esfahani et al. Frontiers in Oncology
- New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors
- (2021) Watson P. Folk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
- (2021) Chandra K. Maharjan et al. Cancers
- A phase II trial of everolimus in patients with advanced pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-containing chemotherapy (NECTOR trial)
- (2020) Hiroyuki Okuyama et al. NEUROENDOCRINOLOGY
- ATM, ATR and DNA-PKcs kinases—the lessons from the mouse models: inhibition ≠ deletion
- (2020) Demis Menolfi et al. Cell and Bioscience
- Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges
- (2020) Jie Yan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Roles for MDC1 in cancer development and treatment
- (2020) Sophie Ruff et al. DNA REPAIR
- Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
- (2020) Elisabetta Cavalcanti et al. Frontiers in Oncology
- Role of tissue and circulating microRNA and DNA as biomarkers in medullary thyroid cancer
- (2020) Martina Chiacchiarini et al. PHARMACOLOGY & THERAPEUTICS
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms
- (2019) Edward Wolin et al. PLoS One
- Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
- (2018) Paola Romeo et al. ENDOCRINE-RELATED CANCER
- Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing
- (2018) Nicole Panarelli et al. ENDOCRINE-RELATED CANCER
- Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC
- (2018) Noushin Shabani et al. HUMAN PATHOLOGY
- The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)
- (2018) Kurt G. Pike et al. JOURNAL OF MEDICINAL CHEMISTRY
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- (2018) Stephen T. Durant et al. Science Advances
- Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors
- (2018) Mark Stevenson et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
- (2018) Guido Rindi et al. MODERN PATHOLOGY
- miRWalk: An online resource for prediction of microRNA binding sites
- (2018) Carsten Sticht et al. PLoS One
- Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Mauro Cives et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- The safety of available treatments options for neuroendocrine tumors
- (2017) A. Faggiano et al. Expert Opinion On Drug Safety
- Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
- (2017) Moritz Jesinghaus et al. MODERN PATHOLOGY
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
- (2017) Elisabetta Cavalcanti et al. Cell Death & Disease
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus
- (2016) Simron Singh et al. CANCER TREATMENT REVIEWS
- Pathologic Classification of Neuroendocrine Neoplasms
- (2016) David S. Klimstra HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
- (2016) C. De Divitiis et al. Journal of Translational Medicine
- Next-generation sequencing in thyroid cancer
- (2016) Yoon Jin Cha et al. Journal of Translational Medicine
- Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature
- (2016) Antongiulio Faggiano et al. ONCOLOGIST
- Management of advanced medullary thyroid cancer
- (2016) Julien Hadoux et al. Lancet Diabetes & Endocrinology
- GOplot: an R package for visually combining expression data with functional analysis: Fig. 1.
- (2015) Wencke Walter et al. BIOINFORMATICS
- Expression Pattern of Carbonic Anhydrase IX in Medullary Thyroid Carcinoma Supports a Role for RET-Mediated Activation of the HIF Pathway
- (2014) Martina Takacova et al. AMERICAN JOURNAL OF PATHOLOGY
- The cellular response to DNA damage: A focus on MDC1 and its interacting proteins
- (2014) Gideon Coster et al. Nucleus
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- The genomic landscape of small intestine neuroendocrine tumors
- (2013) Michaela S. Banck et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- (2013) Joshua M Francis et al. NATURE GENETICS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations inRETandRAS
- (2012) Nishant Agrawal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
- (2012) Mohid S. Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- wANNOVAR: annotating genetic variants for personal genomes via the web
- (2012) Xiao Chang et al. JOURNAL OF MEDICAL GENETICS
- De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer
- (2012) Xiwei Wu et al. Journal of Translational Medicine
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Identification of Unknown Primary Tumors in Patients With Neuroendocrine Liver Metastases
- (2010) Sam C. Wang ARCHIVES OF SURGERY
- mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
- (2010) Hakan Cam et al. MOLECULAR CELL
- The Pathologic Classification of Neuroendocrine Tumors
- (2010) David S. Klimstra et al. PANCREAS
- ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
- (2010) A. Alexander et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circos: An information aesthetic for comparative genomics
- (2009) M. Krzywinski et al. GENOME RESEARCH
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started